AP497A - Novel subcutaneous implants based on nomegestrol derivatives and the processes for their production. - Google Patents

Novel subcutaneous implants based on nomegestrol derivatives and the processes for their production. Download PDF

Info

Publication number
AP497A
AP497A APAP/P/1993/000576A AP9300576A AP497A AP 497 A AP497 A AP 497A AP 9300576 A AP9300576 A AP 9300576A AP 497 A AP497 A AP 497A
Authority
AP
ARIPO
Prior art keywords
implant
implant according
methyl
pregna
active ingredient
Prior art date
Application number
APAP/P/1993/000576A
Other languages
English (en)
Other versions
AP9300576A0 (en:Method
Inventor
Michel Lanquetin
Jean-Louis Thomas
Jacques Paris
Elsimar Coutinho
Original Assignee
Laboratoire Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Theramex filed Critical Laboratoire Theramex
Publication of AP9300576A0 publication Critical patent/AP9300576A0/xx
Application granted granted Critical
Publication of AP497A publication Critical patent/AP497A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
APAP/P/1993/000576A 1992-09-21 1993-09-21 Novel subcutaneous implants based on nomegestrol derivatives and the processes for their production. AP497A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9211422A FR2695826B1 (fr) 1992-09-21 1992-09-21 Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.

Publications (2)

Publication Number Publication Date
AP9300576A0 AP9300576A0 (en:Method) 1993-10-31
AP497A true AP497A (en) 1996-05-28

Family

ID=9433868

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1993/000576A AP497A (en) 1992-09-21 1993-09-21 Novel subcutaneous implants based on nomegestrol derivatives and the processes for their production.

Country Status (31)

Country Link
US (1) US5565443A (en:Method)
EP (1) EP0613372B1 (en:Method)
JP (1) JPH08506318A (en:Method)
KR (1) KR100255700B1 (en:Method)
CN (1) CN1095667C (en:Method)
AP (1) AP497A (en:Method)
AT (1) ATE198275T1 (en:Method)
AU (1) AU683423B2 (en:Method)
BG (1) BG62317B1 (en:Method)
BR (1) BR9305642A (en:Method)
CA (1) CA2122827A1 (en:Method)
CZ (1) CZ284806B6 (en:Method)
DE (1) DE69329790D1 (en:Method)
DZ (1) DZ1717A1 (en:Method)
EC (1) ECSP930986A (en:Method)
FI (1) FI942272L (en:Method)
FR (1) FR2695826B1 (en:Method)
HU (1) HUT67044A (en:Method)
IL (1) IL107039A (en:Method)
MA (1) MA22978A1 (en:Method)
NO (1) NO306238B1 (en:Method)
OA (1) OA09924A (en:Method)
PL (1) PL176120B1 (en:Method)
RO (1) RO115783B1 (en:Method)
RU (1) RU2120797C1 (en:Method)
SK (1) SK54694A3 (en:Method)
TN (1) TNSN93104A1 (en:Method)
TW (1) TW381024B (en:Method)
WO (1) WO1994006437A1 (en:Method)
YU (1) YU60493A (en:Method)
ZA (1) ZA936964B (en:Method)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5660848A (en) * 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
FR2737411B1 (fr) * 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
US6117441A (en) * 1998-07-02 2000-09-12 The Population Council, Inc. Silicone core long term androgen delivery implant
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
GB2355728A (en) * 1999-10-27 2001-05-02 Anson Medical Ltd Tubular medical implants and methods of manufacture
ES2283665T3 (es) 2000-08-03 2007-11-01 Antares Pharma Ipl Ag Composicion para administracion transdermica y/o transmucosa de compuestos activos que asegura unos niveles terapeuticamente adecuados.
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
US7198801B2 (en) 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
MXPA04000156A (es) 2001-06-29 2005-06-06 Medgraft Microtech Inc Implantes inyectables biodegradables y metodos relacionados de fabricacion y uso.
EP2561860B1 (en) * 2002-05-31 2018-02-28 Titan Pharmaceuticals, Inc. Implantable polymeric device for sustained release of buprenorphine
CN102772357B (zh) 2003-03-31 2014-12-31 泰坦医药品公司 用于持续释放多巴胺受体激动剂的可植入聚合物装置
MXPA05012768A (es) * 2003-05-30 2006-02-22 Titan Pharmaceuticals Inc Dispositivo polimerico implantable para liberacion prolongada de nalmefeno.
AU2004283431B2 (en) 2003-10-10 2009-09-10 Antares Pharma Ipl Ag Transdermal pharmaceutical formulation for minimizing skin residues
US7425340B2 (en) 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
US8541028B2 (en) 2004-08-04 2013-09-24 Evonik Corporation Methods for manufacturing delivery devices and devices thereof
US8067399B2 (en) 2005-05-27 2011-11-29 Antares Pharma Ipl Ag Method and apparatus for transdermal or transmucosal application of testosterone
NZ571460A (en) 2006-04-21 2010-10-29 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
FR2904213B1 (fr) * 2006-07-27 2008-10-10 Creaspine Soc Par Actions Simp Implant intervertebral destine a la fusion osseuse
WO2009085952A1 (en) 2007-12-20 2009-07-09 Brookwood Pharmaceuticals, Inc. Process for preparing microparticles having a low residual solvent volume
EP2140860A1 (en) * 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
GB2555373A (en) * 2016-08-23 2018-05-02 Reproductive Medicine And Gynaecology Associates Ltd Implant

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992001706A1 (fr) * 1990-07-20 1992-02-06 Laboratoire Theramex S.A. Nouveaux derives de la 6-methyl 19-nor progesterone, substitue en 3 et leur procede d'obtention

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4147783A (en) * 1974-02-28 1979-04-03 Akzona Incorporated Oral pharmaceutical preparation
GB1515284A (en) * 1974-05-21 1978-06-21 Gastaud J Pharmaceutical compositions containing progestogens derived from the 17-alpha-hydroxy-19-nor-progesterone series
US4172132A (en) * 1977-07-26 1979-10-23 Schering Corporation 1,3,5(10),6,8,14-19-Nor-pregnahexaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor
HU182775B (en) * 1981-10-15 1984-03-28 Richter Gedeon Vegyeszet Process for preparing new 3-chloro-pregnane derivatives
US5223492A (en) * 1987-10-27 1993-06-29 Nasraoui Nejib M Derivatives of 19-nor progesterone; process for producing them and the pharmaceutical compositions incorporating them

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992001706A1 (fr) * 1990-07-20 1992-02-06 Laboratoire Theramex S.A. Nouveaux derives de la 6-methyl 19-nor progesterone, substitue en 3 et leur procede d'obtention

Also Published As

Publication number Publication date
BR9305642A (pt) 1996-01-09
BG98776A (bg) 1995-02-28
CZ284806B6 (cs) 1999-03-17
FI942272A0 (fi) 1994-05-16
FI942272A7 (fi) 1994-05-16
ZA936964B (en) 1994-04-14
OA09924A (fr) 1994-09-15
DZ1717A1 (fr) 2002-02-17
EP0613372A1 (fr) 1994-09-07
RO115783B1 (ro) 2000-06-30
DE69329790D1 (de) 2001-02-01
KR100255700B1 (ko) 2000-08-01
AU683423B2 (en) 1997-11-13
TNSN93104A1 (fr) 1994-03-17
IL107039A0 (en) 1993-12-28
YU60493A (sh) 1997-01-08
ECSP930986A (es) 1994-04-12
MA22978A1 (fr) 1994-04-01
FR2695826A1 (fr) 1994-03-25
AU4822993A (en) 1994-04-12
CN1094284A (zh) 1994-11-02
CA2122827A1 (fr) 1994-03-31
BG62317B1 (bg) 1999-08-31
NO941900L (no) 1994-05-24
EP0613372B1 (fr) 2000-12-27
NO306238B1 (no) 1999-10-11
HUT67044A (en) 1995-01-30
TW381024B (en) 2000-02-01
FI942272L (fi) 1994-05-16
WO1994006437A1 (fr) 1994-03-31
FR2695826B1 (fr) 1995-01-06
SK54694A3 (en) 1994-10-05
PL176120B1 (pl) 1999-04-30
ATE198275T1 (de) 2001-01-15
CN1095667C (zh) 2002-12-11
RU2120797C1 (ru) 1998-10-27
US5565443A (en) 1996-10-15
JPH08506318A (ja) 1996-07-09
AP9300576A0 (en:Method) 1993-10-31
HU9401395D0 (en) 1994-08-29
IL107039A (en) 1999-01-26
CZ116494A3 (en) 1995-03-15
NO941900D0 (no) 1994-05-20

Similar Documents

Publication Publication Date Title
AP497A (en) Novel subcutaneous implants based on nomegestrol derivatives and the processes for their production.
AU781555B2 (en) Devices for the delivery of drugs having antiprogestinic properties
EP0291838B1 (en) Oral drug delivery formulation and method for preparing same
US4346709A (en) Drug delivery devices comprising erodible polymer and erosion rate modifier
US5733565A (en) Male contraceptive implant
JP2001524124A (ja) テストステロンおよびテストステロン前駆体の投与のための膣内薬物送達用具
HU223690B1 (hu) Szilikonmaggal rendelkező hosszan tartóan androgént adagoló implantátum
CN1382500A (zh) 阴道环制剂及其应用
CN116392450A (zh) 含雌激素的皮下植入物及其制备方法
Moghissi et al. An intracervical contraceptive device